查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2013009

大腸鏡設備市場：按組件、治療領域和最終用戶分類－2026-2032年全球市場預測

Colonoscopy Device Market by Component, Therapeutic Area, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年大腸鏡設備市場價值為 23.8 億美元，預計到 2026 年將成長至 25.7 億美元，複合年成長率為 8.07%，到 2032 年將達到 41.1 億美元。

主要市場統計數據
基準年 2025 23.8億美元
預計年份：2026年 25.7億美元
預測年份 2032 41.1億美元
複合年成長率 (%) 8.07%

策略部署正在重塑全球大腸鏡檢查設備的部署，概述了臨床需求、技術進步和護理路徑的變化。

在臨床需求、技術創新以及對患者療效日益重視的推動下，大腸鏡設備市場目前正經歷重大變革。近年來，影像技術、人體工學和一次性耗材技術的進步，促使臨床實踐轉向以診斷準確性和操作效率為優先的檢查方法。同時，篩檢模式也正在適應公共衛生需求，隨著終端使用者尋求能夠簡化不同醫療機構工作流程的設備，連續性醫療服務也不斷發展。

臨床方案、影像技術和經營模式的進步，正在為大腸鏡設備市場和醫療保健服務體系帶來哪些結構性變化？

大腸鏡設備在臨床實踐、技術發展和供應鏈結構等方面正經歷重大變革，這些變革將全面重塑大腸鏡設備的競爭格局。在臨床方面，人們越來越重視預防醫學和早期檢測方案，這推動了對影像能力的投資，以提高病變的檢出率和特徵分析能力。同時，影像光學、感測器小型化和人工智慧影像分析方面的創新，為即時決策支援和提高手術精準度創造了新的可能性。

2025 年關稅變化對大腸鏡設備供應鏈的採購、製造地和採購韌性的多方面影響。

關稅的引入和貿易政策的轉變（將於2025年生效）對大腸鏡設備的採購、製造和定價策略產生了複雜的連鎖反應。對於進口成品或關鍵零件的公司而言，關稅帶來的成本增加迫使它們重新評估採購地點和供應商合約。一些製造商採取的因應措施包括：將生產設施遷至其他地區、重新設計供應鏈以降低關稅風險，或協商長期採購合約以穩定投入成本。

基於可操作的細分洞察，使設備設計、服務模式和臨床證據與組件、治療領域和最終用戶的多樣化需求保持一致。

深入了解市場區隔對於在整個大腸鏡市場中優先進行研發和商業化工作至關重要。按組件分類，該生態系統由「大腸鏡設備」、「大腸鏡配件」和「影像顯示系統」組成，其中大腸鏡設備可進一步細分為「光纖結腸鏡」和「視訊大腸鏡」。每個組件類別都有其獨特的開發路徑。光纖技術在某些傳統應用中仍然至關重要，而視訊大腸鏡由於影像品質的提升和整合功能的增強，正逐漸成為新投資的主流。配件是持續的收入來源，並影響整體擁有成本，而視覺化系統則日益成為增值軟體和分析功能的平台。

我們透過提供可操作的區域洞察，幫助您制定業務擴大策略，這些洞察突顯了美洲、歐洲、中東和非洲以及亞太地區在監管、還款和採用方面的細微差異。

區域趨勢正在塑造美洲、歐洲、中東和非洲以及亞太地區在產品部署、監管溝通和商業性夥伴關係方面的不同策略重點。在美洲，已建立的篩檢項目和簡化流程的措施正在影響市場需求，推動對高解析度視覺化和工作流程最佳化能力的投資。該地區的監管路徑要求提供強力的臨床證據和上市後監測，因此轉化臨床研究和真實世界數據 (RWE) 計畫成為新參與企業和成熟企業的首要任務。

透過技術整合、以證據為基礎的合作以及以服務為導向的商業化模式，企業層面的競爭力得以提升，從而實現長期差異化。

醫療設備製造商、影像專家和耗材供應商之間的競爭動態日益受到能力整合、證據產生和服務交付模式的影響。領先機構正投資於跨學科合作，將光學技術和軟體分析相結合，從而提高診斷靈敏度，並支援臨床路徑和保險報銷相關流程的記錄。同時，小規模但高度專業化的創新者往往在一次性產品、易於消毒的設計或一次性光學元件方面取得突破性進展，直接應對感染控制的優先事項和營運限制。

為醫療設備製造商和醫療保健系統領導者提供具體而有影響力的建議，以使其產品設計、供應彈性和商業化與臨床和經濟優先事項保持一致。

產業領導者必須採取果斷行動，透過協調產品開發、供應鏈策略和商業性執行，將顛覆性趨勢轉化為永續的競爭優勢。應優先採用模組化設計方法，實現視覺化和分析功能的分階段升級，而無需徹底更換設備，從而延長設備使用壽命，降低買家對資本投資的抵觸情緒。同樣重要的是，盡可能實現供應商多元化和近岸外包，以降低關稅風險和物流瓶頸，同時確保品管和合規性。

對用於得出有關大腸鏡設備的臨床意義和商業性意義的研究結果的研究方法、資料來源和檢驗程序進行透明的解釋。

這項高階主管分析的研究結合了系統性的二手資料研究和有針對性的一手資料研究，以確保研究結果基於臨床實踐和實際操作情況。二級資訊來源包括同行評審的臨床文獻、監管文件和行業白皮書，旨在了解技術進步、安全考量和標準治療方案。這些研究成果與對執業內視鏡醫師、採購經理和生物醫學工程師的一手訪談進行了交叉比對，以收集關於可用性、培訓需求和採購標準的實際觀點。

簡潔扼要的結論整合了策略重點和必要的權衡取捨，這些因素決定了大腸鏡設備市場新產品上市的成功率和長期影響。

總而言之，大腸鏡設備領域呈現出以下幾個面向的融合趨勢：臨床對更高檢測能力的需求、影像和分析技術的進步，以及採購趨勢和政策變化帶來的商業性調整。這些因素為產品差異化開闢了清晰的路徑：卓越的可視化和整合分析能力能夠創造臨床價值；穩健的供應鍊和本地化能力能夠降低營運風險；循證服務模式能夠獲得保險公司和醫療服務提供者的支持。能夠將產品創新與切實可行的部署策略和嚴格的臨床檢驗相結合的相關人員，將更有能力影響標準診療流程，並確保在各種醫療環境中得到永續應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 大腸鏡設備市場：依組件分類

  • 大腸鏡檢查裝置
    • 纖維光學大腸鏡檢查
    • 視訊大腸鏡檢查
  • 大腸鏡檢查配件
  • 影像顯示系統

第9章：大腸鏡設備市場：依治療領域分類

  • 結腸癌
  • 克隆氏症
  • 林奇症候群
  • 潰瘍性大腸炎

第10章：大腸鏡設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 診斷中心
  • 醫院
  • 研究所

第11章 大腸鏡設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 大腸鏡設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：大腸鏡設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章：美國大腸鏡設備市場

第15章：中國大腸鏡設備市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ambu A/S
  • Avantis Medical Systems
  • Boston Scientific Corporation
  • ColoWrap, LLC.
  • ConMed Corporation
  • Dantschke Medizintechnik GmbH & Co. KG
  • Endomed Systems GmbH
  • FUJIFILM Holdings Corporation
  • GI View Ltd
  • Getinge AB
  • Hologic, Inc.
  • HOYA Corporation
  • Huger Medical Instrument Co.,Ltd
  • Karl Storz SE & Co. KG
  • Medtronic PLC
  • Olympus Corp.
  • Ottomed Endoscopy by Mitra Medical Services LLP
  • Pro Scope Systems LLC
  • Richard Wolf GmbH
  • SHAILI ENDOSCOPY PRIVATE LIMITED
  • Shanghai Shiyin Photoelectric Instrument Co.,Ltd.
  • Smith & Nephew Plc
  • Sonoscape Medical Corp
  • Steris Corporation
  • Stryker Corporation
Product Code: MRR-431B7BFFBF3C

The Colonoscopy Device Market was valued at USD 2.38 billion in 2025 and is projected to grow to USD 2.57 billion in 2026, with a CAGR of 8.07%, reaching USD 4.11 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.38 billion
Estimated Year [2026] USD 2.57 billion
Forecast Year [2032] USD 4.11 billion
CAGR (%) 8.07%

A strategic introduction outlining clinical imperatives, technological momentum, and care pathway changes that are reshaping colonoscopy device deployment worldwide

The landscape of colonoscopy devices is in the midst of a substantive transformation driven by clinical demand, technological innovation, and heightened emphasis on patient outcomes. Over recent years, advances in visualization, ergonomics, and disposable technologies have shifted clinical practice toward procedures that prioritize diagnostic accuracy and procedural efficiency. At the same time, the care continuum is evolving as screening paradigms adapt to population health imperatives and as end users seek devices that streamline workflows in diverse care settings.

Clinicians and procurement teams now expect devices that deliver superior imaging, reduced downtime, and enhanced infection control, while health systems weigh capital investment against throughput and long-term operational costs. Meanwhile, manufacturers face growing pressure to demonstrate clinical value through evidence generation and to design solutions that integrate with existing information systems. These intersecting forces create both opportunities and constraints that must be navigated with a clear grasp of clinical needs, regulatory expectations, and commercial realities.

In this context, the role of colonoscopy devices extends beyond instrumentation to include procedural protocols, training, and post-procedure data management. As such, stakeholders must consider not only the technology itself but also how devices interact with accessories, visualization systems, and end-user environments to deliver reliable clinical outcomes and sustainable service delivery models

How converging advances in clinical protocols, imaging technology, and commercial models are driving structural changes in colonoscopy device markets and care delivery

Significant shifts are underway across clinical practice, technology development, and supply chain configurations that collectively redefine competitive dynamics in colonoscopy devices. On the clinical front, there is an accelerating focus on preventive care and early detection protocols, prompting investment in imaging capabilities that improve lesion detection and characterization. Concurrently, innovations in video optics, sensor miniaturization, and AI-enabled image analysis are creating new possibilities for real-time decision support and enhanced procedural confidence.

From a commercial perspective, business models are evolving as manufacturers experiment with service-oriented offerings, bundled consumables, and hybrid capital-asset approaches that reduce upfront friction for buyers. Regulatory frameworks are adapting to these shifts, placing greater emphasis on post-market surveillance and cybersecurity for connected visualization systems. Moreover, buy-side behavior is changing: hospitals and outpatient centers increasingly favor devices that reduce turnover time and support standardized training pathways for staff.

These combined dynamics necessitate strategic choices around product portfolios, channel strategies, and evidence generation. In particular, the integration of digital tools and interoperability features represents a transformative axis, enabling better procedural analytics and extended value propositions. As a result, organizations that align clinical validation with pragmatic deployment strategies are positioned to capture long-term adoption and to influence standards of care across diverse clinical settings

The multifaceted consequences of 2025 tariff changes on procurement, manufacturing footprints, and procurement resilience across colonoscopy device supply chains

The introduction of tariffs and trade policy shifts that took effect in 2025 has produced complex ripple effects across procurement, manufacturing, and pricing strategies for colonoscopy devices. For organizations importing finished devices or key subcomponents, tariff-related cost increases compelled reassessment of sourcing footprints and supplier contracts. Some manufacturers responded by shifting production to alternative jurisdictions, by redesigning supply chains to reduce tariff exposure, or by negotiating longer-term procurement agreements to stabilize input costs.

Hospitals and ambulatory centers experienced indirect impacts through higher acquisition and consumable expenses, which in turn influenced capital expenditure planning and device replacement cycles. Procurement teams increasingly prioritized suppliers with localized production capabilities or with demonstrable resilience in logistics to avoid disruption. In addition, the tariffs elevated the importance of regulatory alignment and classification clarity, since reclassification of certain components or assemblies affected duty treatment and compliance costs.

Policy change also accelerated strategic conversations about nearshoring and vertical integration. Some firms pursued greater in-country assembly or component sourcing to mitigate tariff exposure and shorten lead times, thereby improving service responsiveness. Meanwhile, payer and provider negotiations reflected heightened scrutiny of total cost of care, prompting renewed emphasis on device durability, reprocessing efficiency, and procedural throughput as levers to offset higher upfront outlays. Overall, the 2025 tariff environment reinforced the need for agile commercial models, diversified supplier networks, and careful lifecycle cost analysis in procurement decision-making

Practical segmentation-driven insights that align device design, service models, and clinical evidence with differentiated needs across components, therapeutic areas, and end users

A granular understanding of segmentation is essential to prioritize development and commercialization efforts across the colonoscopy device landscape. By component, the ecosystem encompasses Colonoscope Devices, Colonoscopy Accessories, and Visualization Systems, with Colonoscope Devices further divided into Fiber-optic Colonoscopes and Video Colonoscopes. Each component category presents distinct development pathways: fiber-optic technology retains relevance in specific legacy applications while video colonoscopes dominate new investments due to improved imaging and integration capabilities. Accessories play a recurring revenue role and influence total cost of ownership, whereas visualization systems increasingly act as platforms for value-added software and analytics.

Across therapeutic areas, demand drivers vary according to clinical complexity and screening protocols, with Colorectal Cancer representing a primary focus for sensitivity and specificity improvements. Management of inflammatory bowel disease conditions such as Crohn's Disease and Ulcerative Colitis creates demand for devices that support therapeutic interventions and enhanced mucosal visualization, while genetic-risk monitoring for Lynch Syndrome emphasizes surveillance strategies and repeat-procedure considerations. These clinical distinctions shape product requirements, evidence generation priorities, and post-market support models.

End-user segmentation further refines market approach because adoption dynamics and procurement processes differ markedly across Ambulatory Surgical Centers, Clinics, Diagnostic Centers, Hospitals, and Research Laboratories. Ambulatory centers often prioritize throughput and simplified procedures, clinics may emphasize affordability and ease of use, diagnostic centers focus on specialized imaging and workflow optimization, hospitals balance capital investment with cross-department utility, and research laboratories require advanced customization and data capture. Tailoring product features, service models, and training to these differentiated needs is critical for successful commercialization and sustained utilization

Actionable regional insights highlighting regulatory, reimbursement, and adoption nuances across the Americas, Europe, Middle East & Africa, and Asia-Pacific to inform expansion strategies

Regional dynamics shape strategic priorities for product rollouts, regulatory engagement, and commercial partnerships in distinct ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. Within the Americas, demand is influenced by established screening programs and a drive toward procedural efficiency, prompting investment in high-definition visualization and workflow-enhancing features. Regulatory pathways in the region require robust clinical evidence and post-market surveillance, making translational clinical studies and real-world evidence programs high priorities for new entrants and incumbents alike.

The Europe, Middle East & Africa region presents a heterogeneous environment where reimbursement frameworks and procurement processes vary significantly across national and subnational markets. In many parts of this region, public procurement mechanisms favor cost-effectiveness and lifecycle reliability, while some advanced care centers pursue cutting-edge imaging capabilities, creating a dual-track demand profile. Localization of service networks and training programs is often necessary to secure sustainable adoption in this complex regulatory and payer landscape.

Asia-Pacific is notable for rapid capacity expansion, growing adoption of outpatient and diagnostic center models, and a strong interest in cost-competitive innovations. Manufacturers frequently adapt product portfolios and pricing strategies to meet diverse economic conditions and heterogeneous clinical needs across the region. In each geography, partnerships with local distributors, investment in training, and alignment with regional regulatory expectations are essential levers for market entry and long-term performance

Competitive company-level dynamics driven by technology integration, evidence partnerships, and service-oriented commercialization models that determine long-term differentiation

Competitive dynamics among device manufacturers, imaging specialists, and consumables suppliers are increasingly defined by capability integration, evidence generation, and service delivery models. Leading organizations invest in cross-disciplinary collaborations that link optical engineering with software analytics, thereby enhancing diagnostic sensitivity and enabling procedural documentation that supports clinical pathways and reimbursement discussions. At the same time, smaller, focused innovators often drive disruptive advances in disposables, sterilization-friendly designs, or single-use optics that respond directly to infection control priorities and operational constraints.

Strategic partnerships between manufacturers and clinical research networks have become an important mechanism to generate the prospective clinical validation required by purchasers and regulators. Similarly, companies that offer end-to-end solutions-combining colonoscope hardware, visualization platforms, consumables, and training-create stronger value propositions for multi-site health systems seeking standardized protocols and predictable service outcomes. Transitioning from transactional sales to outcome-oriented contracts and bundled purchasing arrangements is emerging as a differentiator for firms that can demonstrate improved workflow efficiency and patient outcomes.

Capital markets and private equity interest have also influenced competitive behavior, providing growth capital for product development and market expansion while accelerating consolidation in particular subsegments. This environment rewards management teams that can articulate a clear path to clinical impact, scalable service operations, and resilient supply chains

Concrete, high-impact recommendations for device makers and health system leaders to align product design, supply resilience, and commercialization with clinical and economic priorities

Industry leaders must act decisively to translate disruptive trends into sustainable competitive advantage by aligning product development, supply chain strategy, and commercial execution. Prioritize modular design approaches that enable incremental upgrades to visualization and analytics without necessitating full instrument replacement, thereby extending device lifecycles and reducing buyer resistance to capital investment. Equally important is diversification of the supplier base and nearshoring where feasible to mitigate tariff exposure and logistical bottlenecks while preserving quality control and regulatory compliance.

Investing in rigorous clinical validation and real-world evidence programs will accelerate payer acceptance and support premium positioning based on demonstrable clinical benefits. Trainings and certification pathways for end users can reduce variability in procedural outcomes and strengthen value arguments for advanced imaging systems. From a commercial standpoint, experiment with flexible pricing models and outcome-linked contracts that share risk with purchasers and highlight total cost of care improvements rather than upfront cost alone.

Finally, build partnerships across healthcare ecosystems-including IT integrators, infection prevention leaders, and clinical training providers-to deliver holistic solutions that address workflow, safety, and data integration. These interdisciplinary collaborations will be instrumental in fostering adoption in diverse care settings and in unlocking long-term relationships with high-volume purchasers

A transparent description of research methods, data sources, and validation steps used to generate clinically grounded and commercially relevant colonoscopy device insights

The research underpinning this executive analysis combined systematic secondary research with targeted primary engagements to ensure findings are grounded in clinical practice and operational realities. Secondary sources included peer-reviewed clinical literature, regulatory documents, and industry white papers to map technological trajectories, safety considerations, and standard-of-care protocols. These insights were triangulated with primary interviews conducted with practicing endoscopists, procurement leaders, and biomedical engineers to capture frontline perspectives on usability, training needs, and purchasing criteria.

Qualitative analysis focused on thematic synthesis of clinical priorities and adoption barriers, while structured interviews provided comparative viewpoints on device performance, reprocessing workflows, and consumable management. Supply chain evaluations incorporated public trade data, vendor disclosures, and expert commentary to analyze sourcing risks and mitigation strategies. To validate conclusions, draft findings were reviewed with external clinical advisors and adjusted to reflect consensus on clinical utility, regulatory constraints, and operational feasibility.

Limitations of the methodology include variability in country-level reimbursement frameworks and the evolving nature of regulatory guidance for connected visualization systems. Nevertheless, integrating diverse data streams and expert validation supports robust, actionable insights for stakeholders seeking to make informed strategic choices in product development, market entry, and procurement planning

A concise conclusion synthesizing strategic priorities and the essential trade-offs that will determine successful adoption and long-term impact in colonoscopy device markets

In summary, the colonoscopy device arena is experiencing a convergence of clinical demand for improved detection, technological advances in imaging and analytics, and commercial adjustments driven by procurement dynamics and policy changes. These forces create distinct pathways to differentiation: superior visualization and integrated analytics produce clinical value, resilient supply chains and localized capabilities reduce operational risk, and evidence-based service models unlock payer and provider buy-in. Stakeholders who synchronize product innovation with pragmatic deployment strategies and rigorous clinical validation will be best positioned to influence standards of care and to secure durable adoption across diverse care settings.

The combined impact of tariffs, regulatory evolution, and shifting end-user priorities underscores the importance of agility and cross-functional collaboration. Whether addressing the specific needs of hospitals, ambulatory centers, diagnostic facilities, or research laboratories, successful organizations will align product, pricing, and training strategies to the operational realities of their target end users. Ultimately, a balanced approach that prioritizes clinical outcomes, total cost of care, and supply resilience will enable sustainable growth and meaningful improvements in patient care

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Colonoscopy Device Market, by Component

  • 8.1. Colonoscope Devices
    • 8.1.1. Fiber-optic Colonoscopes
    • 8.1.2. Video Colonoscopes
  • 8.2. Colonoscopy Accessories
  • 8.3. Visualization Systems

9. Colonoscopy Device Market, by Therapeutic Area

  • 9.1. Colorectal Cancer
  • 9.2. Crohn's Disease
  • 9.3. Lynch Syndrome
  • 9.4. Ulcerative Colitis

10. Colonoscopy Device Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Diagnostic Centers
  • 10.4. Hospitals
  • 10.5. Research Laboratories

11. Colonoscopy Device Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Colonoscopy Device Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Colonoscopy Device Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Colonoscopy Device Market

15. China Colonoscopy Device Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Ambu A/S
  • 16.6. Avantis Medical Systems
  • 16.7. Boston Scientific Corporation
  • 16.8. ColoWrap, LLC.
  • 16.9. ConMed Corporation
  • 16.10. Dantschke Medizintechnik GmbH & Co. KG
  • 16.11. Endomed Systems GmbH
  • 16.12. FUJIFILM Holdings Corporation
  • 16.13. G.I. View Ltd
  • 16.14. Getinge AB
  • 16.15. Hologic, Inc.
  • 16.16. HOYA Corporation
  • 16.17. Huger Medical Instrument Co.,Ltd
  • 16.18. Karl Storz SE & Co. KG
  • 16.19. Medtronic PLC
  • 16.20. Olympus Corp.
  • 16.21. Ottomed Endoscopy by Mitra Medical Services LLP
  • 16.22. Pro Scope Systems LLC
  • 16.23. Richard Wolf GmbH
  • 16.24. SHAILI ENDOSCOPY PRIVATE LIMITED
  • 16.25. Shanghai Shiyin Photoelectric Instrument Co.,Ltd.
  • 16.26. Smith & Nephew Plc
  • 16.27. Sonoscape Medical Corp
  • 16.28. Steris Corporation
  • 16.29. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COLONOSCOPY DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL COLONOSCOPY DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES COLONOSCOPY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA COLONOSCOPY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY FIBER-OPTIC COLONOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY FIBER-OPTIC COLONOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY FIBER-OPTIC COLONOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY VIDEO COLONOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY VIDEO COLONOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY VIDEO COLONOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY VISUALIZATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY VISUALIZATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY CROHN'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY CROHN'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY LYNCH SYNDROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY LYNCH SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY LYNCH SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY ULCERATIVE COLITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY ULCERATIVE COLITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS COLONOSCOPY DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GCC COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GCC COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 97. GCC COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 98. GCC COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 99. GCC COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPEAN UNION COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPEAN UNION COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. BRICS COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 107. BRICS COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. G7 COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. G7 COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 112. G7 COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 113. G7 COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 114. G7 COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NATO COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. NATO COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 117. NATO COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 118. NATO COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 119. NATO COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL COLONOSCOPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. UNITED STATES COLONOSCOPY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. UNITED STATES COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 123. UNITED STATES COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. CHINA COLONOSCOPY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. CHINA COLONOSCOPY DEVICE MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. CHINA COLONOSCOPY DEVICE MARKET SIZE, BY COLONOSCOPE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 129. CHINA COLONOSCOPY DEVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 130. CHINA COLONOSCOPY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)